Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2300 of 3546 entries
View as:

Managed Access Program for Momelotinib in Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT05582083 Org: User:
Start: - End: - Due: -

An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study B

Phase: N/A Priority: Normal
NCT ID: NCT01323660 Org: User:
Start: 03/16/11 End: 07/16/12 Due: 07/16/13

A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01954043 Org: User:
Start: 12/20/13 End: 02/29/16 Due: 02/28/17

Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00743405 Org: User:
Start: 05/02/08 End: 12/15/08 Due: 12/15/09

Drug Use Investigation for IMIGRAN Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01376141 Org: User:
Start: 09/30/01 End: 11/30/05 Due: 11/30/06

A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution

Phase: N/A Priority: Normal
NCT ID: NCT02688361 Org: User:
Start: 02/22/16 End: 04/13/16 Due: 04/13/17

Clinical Study to Test a New Drug to Treat Major Depression

Phase: N/A Priority: Normal
NCT ID: NCT00976560 Org: User:
Start: 09/25/09 End: 07/07/10 Due: 07/07/11

Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00327197 Org: User:
Start: 08/02/05 End: 06/06/11 Due: 06/06/12

A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00920374 Org: User:
Start: 06/16/09 End: 07/08/09 Due: 07/08/10

Dose Escalating Study of CCI15106 Inhalation Capsules in Healthy Subjects and Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT03243760 Org: User:
Start: 02/10/16 End: 08/20/16 Due: 08/20/17

Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older

Phase: N/A Priority: Normal
NCT ID: NCT02735915 Org: User:
Start: 04/11/16 End: 10/08/18 Due: 10/08/19

Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00264680 Org: User:
Start: 10/01/03 End: 03/01/06 Due: 03/01/07

A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01818011 Org: User:
Start: 08/07/13 End: 10/18/13 Due: 10/18/14

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01934127 Org: User:
Start: 08/26/13 End: 10/20/14 Due: 10/20/15

Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.

Phase: N/A Priority: Normal
NCT ID: NCT00263679 Org: User:
Start: 11/30/03 End: 10/31/04 Due: 10/31/05

A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)

Phase: N/A Priority: Normal
NCT ID: NCT00441675 Org: User:
Start: 01/31/07 End: 10/31/07 Due: 10/31/08

A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01357850 Org: User:
Start: 09/15/10 End: 09/18/12 Due: 09/18/13

Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02703181 Org: User:
Start: 07/09/15 End: 09/10/15 Due: 09/10/16

24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00318656 Org: User:
Start: 11/30/05 End: 10/31/07 Due: 10/31/08

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01190176 Org: User:
Start: 09/12/11 End: 09/20/17 Due: 09/20/18

A Study To Investigate The Metabolism Of GW876008 In Smokers Compared To Non-Smokers.

Phase: N/A Priority: Normal
NCT ID: NCT00429728 Org: User:
Start: 11/30/06 End: - Due: -

The Effectiveness of Varicella Vaccination in Children in Germany

Phase: N/A Priority: Normal
NCT ID: NCT00679796 Org: User:
Start: 02/29/08 End: 10/31/10 Due: 10/31/11

Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)

Phase: N/A Priority: Normal
NCT ID: NCT00329355 Org: User:
Start: 05/31/06 End: 11/30/06 Due: 11/30/07

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

Phase: N/A Priority: Normal
NCT ID: NCT00495469 Org: User:
Start: 08/17/07 End: 06/05/08 Due: 06/05/09

Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT00364442 Org: User:
Start: 01/28/05 End: 04/13/05 Due: 04/13/06